Pharmacist Reviews Improved Cancer Patient Care
A new study found that pharmacist-led medication reviews successfully reduced inappropriate drug use in older cancer patients.
Updated on Sept. 29, 2026 in Cancer
Live Poll
Would you ask your doctor for a pharmacist-led medication review to improve your prescription quality?
A clinical study of 443 cancer patients aged 65 or older found that pharmacist-led medication reviews significantly improved treatment quality. By utilizing the Fit fOR The Aged list, researchers reduced occurrences of medication overuse, underuse, and potentially inappropriate prescriptions.
Why it matters
Older patients with cancer often manage complex drug regimens that carry high risks for adverse reactions or ineffective treatment. Standardized reviews provide a structured method to optimize therapy and address significant gaps in preventive care, such as missing vaccinations.
The study utilized a randomized trial involving 443 participants, where 66.1 percent were initially exposed to inappropriate medication. The intervention resulted in a mean reduction of 3.7 points on the FORTA scale compared to the control group.
The players
Journal of Internal Medicine
This is a peer-reviewed medical journal that publishes original research articles in the field of internal medicine.
The details
Researchers in Heidelberg assigned patients to either standard care or a pharmacist-led review that counseled physicians on adjustments. This process also identified 337 missing vaccinations among the intervention group, highlighting the broader role pharmacists can play in patient health management.
Timeline
The study was published in the Journal of Internal Medicine on September 23, 2026.
This report was published on September 29, 2026.
The Big Picture
This study follows the implementation of the Fit fOR The Aged (FORTA) list to refine geriatric prescribing standards. The findings demonstrate that integrating this tool into routine cancer care can effectively bridge the gap between complex drug management and patient safety.
Older patients may benefit from requesting a comprehensive medication review to identify and correct potentially inappropriate drug combinations. This proactive step can help reduce health complications and ensure that necessary preventive measures, like vaccinations, are not overlooked.
The takeaway
Pharmacist-led interventions can significantly reduce the risks associated with polypharmacy in elderly cancer patients. Integrating structured tools like the FORTA list ensures that medication therapy is both safer and more effective for this vulnerable demographic.
Further reading
For more information on the evolving standards of oncology care, visit our Cancer section.
Live Poll
Would you ask your doctor for a pharmacist-led medication review to improve your prescription quality?
